In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates

Background: Latent tuberculosis has been associated with the persistence of dormant Mycobacterium tuberculosis in the organism of infected individuals, who are reservoirs of the bacilli and the source for spreading the disease in the community. New active anti-TB drugs exerting their metabolic actio...

Full description

Bibliographic Details
Main Authors: Imperiale, Belen Rocio, Cataldi, Angel Adrian, Morcillo, Nora
Format: Artículo
Language:Inglés
Published: 2018
Subjects:
Online Access:http://hdl.handle.net/20.500.12123/1961
http://www.elsevier.es/en-revista-revista-argentina-microbiologia-372-resumen-in-vitro-anti-tuberculosis-activity-azole-S0325754117300895
http://dx.doi.org/10.1016/j.ram.2017.02.008
_version_ 1855482970717028352
author Imperiale, Belen Rocio
Cataldi, Angel Adrian
Morcillo, Nora
author_browse Cataldi, Angel Adrian
Imperiale, Belen Rocio
Morcillo, Nora
author_facet Imperiale, Belen Rocio
Cataldi, Angel Adrian
Morcillo, Nora
author_sort Imperiale, Belen Rocio
collection INTA Digital
description Background: Latent tuberculosis has been associated with the persistence of dormant Mycobacterium tuberculosis in the organism of infected individuals, who are reservoirs of the bacilli and the source for spreading the disease in the community. New active anti-TB drugs exerting their metabolic action at different stages and on latent/dormant bacilli are urgently required to avoid endogenous reactivations and to be part of treatments of multi- and extensively-drug resistant tuberculosis (M/XDR-TB). It was previously reported that azole drugs are active against M. tuberculosis. For that reason, the aims of this study were to determine the in vitro activity of azole drugs, imidazole (clotrimazole, CLO and econazole, ECO) and nitroimidazole (metronidazole, MZ and ipronidazole, IPZ), against a collection of MDR M. tuberculosis clinical isolates; and to analyze their potential use in both the LTB and the active forms of M/XDR-TB treatments. Methods: A total of 55 MDR M. tuberculosis isolates and H37Rv were included. MZ and IPZ activity against M. tuberculosis isolates were tested using anaerobic culture conditions. The activity of ECO and CLO was measured by the minimal inhibitory concentration (MIC) using a microdilution colorimetric method.
format Artículo
id INTA1961
institution Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina)
language Inglés
publishDate 2018
publishDateRange 2018
publishDateSort 2018
record_format dspace
spelling INTA19612018-03-05T16:35:47Z In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates Imperiale, Belen Rocio Cataldi, Angel Adrian Morcillo, Nora Mycobacterium Resistencia a Medicamentos Azoles Mycobacterium Tuberculosis Imidazoles Experimentación in Vitro Drug Resistance In Vitro Experimentation Background: Latent tuberculosis has been associated with the persistence of dormant Mycobacterium tuberculosis in the organism of infected individuals, who are reservoirs of the bacilli and the source for spreading the disease in the community. New active anti-TB drugs exerting their metabolic action at different stages and on latent/dormant bacilli are urgently required to avoid endogenous reactivations and to be part of treatments of multi- and extensively-drug resistant tuberculosis (M/XDR-TB). It was previously reported that azole drugs are active against M. tuberculosis. For that reason, the aims of this study were to determine the in vitro activity of azole drugs, imidazole (clotrimazole, CLO and econazole, ECO) and nitroimidazole (metronidazole, MZ and ipronidazole, IPZ), against a collection of MDR M. tuberculosis clinical isolates; and to analyze their potential use in both the LTB and the active forms of M/XDR-TB treatments. Methods: A total of 55 MDR M. tuberculosis isolates and H37Rv were included. MZ and IPZ activity against M. tuberculosis isolates were tested using anaerobic culture conditions. The activity of ECO and CLO was measured by the minimal inhibitory concentration (MIC) using a microdilution colorimetric method. Inst. de Biotecnología Fil: Imperiale, Belen Rocio. Hospital Dr. Antonio A. Cetrángolo. Laboratorio de Referencia del Programa de Control de la Tuberculosis de la provincia de Buenos Aires; Argentina Fil: Cataldi, Angel Adrian. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Biotecnología; Argentina Fil: Morcillo, Nora. Hospital Dr. Antonio A. Cetrángolo. Laboratorio de Referencia del Programa de Control de la Tuberculosis de la provincia de Buenos Aires; Argentina 2018-03-05T15:41:50Z 2018-03-05T15:41:50Z 2017-12 info:eu-repo/semantics/article info:ar-repo/semantics/artículo info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/1961 http://www.elsevier.es/en-revista-revista-argentina-microbiologia-372-resumen-in-vitro-anti-tuberculosis-activity-azole-S0325754117300895 http://dx.doi.org/10.1016/j.ram.2017.02.008 eng info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) application/pdf Revista Argentina de Microbiología 49 (4) : 332-338 (October - December 2017)
spellingShingle Mycobacterium
Resistencia a Medicamentos
Azoles
Mycobacterium Tuberculosis
Imidazoles
Experimentación in Vitro
Drug Resistance
In Vitro Experimentation
Imperiale, Belen Rocio
Cataldi, Angel Adrian
Morcillo, Nora
In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
title In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
title_full In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
title_fullStr In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
title_full_unstemmed In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
title_short In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
title_sort in vitro anti tuberculosis activity of azole drugs against mycobacterium tuberculosis clinical isolates
topic Mycobacterium
Resistencia a Medicamentos
Azoles
Mycobacterium Tuberculosis
Imidazoles
Experimentación in Vitro
Drug Resistance
In Vitro Experimentation
url http://hdl.handle.net/20.500.12123/1961
http://www.elsevier.es/en-revista-revista-argentina-microbiologia-372-resumen-in-vitro-anti-tuberculosis-activity-azole-S0325754117300895
http://dx.doi.org/10.1016/j.ram.2017.02.008
work_keys_str_mv AT imperialebelenrocio invitroantituberculosisactivityofazoledrugsagainstmycobacteriumtuberculosisclinicalisolates
AT cataldiangeladrian invitroantituberculosisactivityofazoledrugsagainstmycobacteriumtuberculosisclinicalisolates
AT morcillonora invitroantituberculosisactivityofazoledrugsagainstmycobacteriumtuberculosisclinicalisolates